Lackluster (a.k.a. Esa Ruoho) - LL7 26/05/00 (Dear Laurent) (Rikos Records/FIN/Merck/USA, 2000/2001/2003).
Originally RIKOS-005 7" on Jyväskylä's legendary Rikos Records; later re-released by Florida's Merck label (7" in 2001, Lackluster's "Showcase" compilation in 2003).
https://youtu.be/3VXAEcCk5WA?si=BT7MqAfDLAEJty0w
#Lackluster #IDM #electro #electronic #RikosRecords #Jyväskylä #Merck #Miami #Florida #USA #EsaRuoho #Finland
CounterPunch.org | Drug Ads Are Deceptive and Deadly by Brandon Novick
AI generated summary, Read the full article for complete information.
The piece argues that direct‑to‑consumer prescription‑drug advertising in the United States is both misleading and hazardous, as companies spend billions on emotional marketing that omits crucial risk information while exaggerating benefits; this practice drives Americans to pay far more for less effective, pricier drugs, contributes to serious health harms—including deaths linked to misleading ads for products like Vioxx—and undermines public health. Because only the U.S. and New Zealand permit such ads, the author urges Congress to curb deceptive marketing by requiring clear, prominent disclosure of all risks, imposing hefty fines, and eliminating liability shields, thereby making false advertising unprofitable and encouraging the development and promotion of genuinely safe, effective treatments.
Read more: https://www.counterpunch.org/2026/05/18/drug-ads-are-deceptive-and-deadly/
@ducky
Understood. And that seems like a fair point.
Regarding #VAERS, it is open for all vaccine reporting, not only #COVID, and the reports for the COVID shot are greater in number than all other vaccines combined, including current vaccines for other illnesses (like flu). This is significant data.
I visited your website, so I know who I am dealing with here. You are on the side of the big pharmaceutical companies, like #Pfizer and #Merck.
(You might want to fix the spelling.)
US Top News and Analysis | Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
AI generated summary, Read the full article for complete information.
Bristol Myers Squibb announced a multi‑billion‑dollar partnership with China’s top drugmaker Hengrui Pharma to develop roughly a dozen new medicines, including four experimental compounds that BMS will send to China for early‑stage clinical testing. Unlike typical licensing deals where U.S. firms outsource Chinese discoveries, this reciprocal arrangement has both companies contributing assets and jointly discovering novel drugs, signaling a shift toward a “global mesh” model of R&D. Industry observers note that American and European biopharma firms are increasingly turning to China for faster, cheaper early‑stage research—potentially cutting development time by half and costs by two‑thirds—while later‑stage trials remain U.S.‑centric to satisfy FDA requirements. The deal underscores China’s growing role as a central hub in global drug development rather than merely a source of one‑off molecules.
#BristolMyers #HengruiPharma #Pfizer #Merck #AstraZeneca #EliLilly #MichaelBaran #McKinsey #DealForma #FDA # #LievenVanderVeken
quantum computers can be networked now, more usable qubits will be able to be connected
more 'breakthroughs' will end up happening, things go slow at the start
#ibm #cleveland clinic #folding #enzymes #trypsin #catalysts #sims #merck index #buffer systems #chirality #nextplatform.com
Blue chip companies including #Merck, #Citi and #HomeDepot will expand use of #Google #Gemini Enterprise #AI agents on a revamped platform, but how far its appeal will extend beyond the #GoogleCloud user base remains to be seen.
My writeup features comments from interviews and sessions at #GoogleCloudNext:
Merck Strikes $1B AI Deal with Google Cloud to Transform Drug R&D
Merck is shaking up the future of drug research and development with a groundbreaking $1 billion deal with Google Cloud, harnessing the power of artificial intelligence to speed up scientific breakthroughs and bring life-changing treatments to patients faster. By combining forces, they'll create an AI-enabled enterprise that…
#ArtificialIntelligence #GoogleCloud #Merck #Pharmaceutical #Healthcare
#Merck #multinationalCompanies #taxheaven
Aux Pays-Bas, les multinationales bénéficient toujours d’avantages fiscaux considérables, révèle une enquête
https://www.icij.org/investigations/cancer-calculus/merck-keytruda-cancer-drug-price/
pHinnWeb
((***Tiefenkultur**)) @kassiopeia_v7
The Bad Place
Earl
gary
Beth Pariseau
Analyst207
Jens Joachim
Paradis Fiscaux et Judiciaires